Speaking of SurgOnc
By Annals of Surgical Oncology and Society of Surgical Oncology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 55
Description
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
| Episode | Date |
|---|---|
|
Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
|
Apr 09, 2024 |
|
Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
|
Mar 12, 2024 |
|
Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?
|
Feb 13, 2024 |
|
Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study
|
Jan 09, 2024 |
|
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
|
Dec 12, 2023 |
|
Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients
|
Nov 14, 2023 |
|
Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects
|
Oct 10, 2023 |
|
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer
|
Sep 12, 2023 |
|
Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center
|
Aug 08, 2023 |
|
Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT
|
Jul 11, 2023 |
|
A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases
|
Jun 13, 2023 |
|
Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients
|
May 09, 2023 |
|
Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
|
Apr 11, 2023 |
|
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)
|
Mar 14, 2023 |
|
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers
|
Feb 14, 2023 |
|
Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy with and without Reconstruction
|
Jan 10, 2023 |
|
Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States
|
Dec 20, 2022 |
|
Surgical Approach Does Not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study
|
Nov 22, 2022 |
|
Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
|
Oct 11, 2022 |
|
The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy
|
Aug 16, 2022 |
|
Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?”
|
Jul 13, 2022 |
|
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
|
Jun 14, 2022 |
|
COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States
|
May 10, 2022 |
|
Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation
|
Apr 19, 2022 |
|
A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction
|
Mar 15, 2022 |
|
Cultural Complications Curriculum: Applicability to Surgical Oncology Programs and Practices
|
Feb 08, 2022 |
|
Introducing the Ongoing Clinical Trials in the Surgical Oncology Series
|
Jan 11, 2022 |
|
Landmark Series on Disparities in Surgical Oncology: Melanoma
|
Dec 14, 2021 |
|
Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control
|
Nov 09, 2021 |
|
Impact of the COVID-19 Pandemic on Cancer Clinical Trials
|
Oct 12, 2021 |
|
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
|
Aug 10, 2021 |
|
Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines
|
Jul 13, 2021 |
|
Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons
|
Jun 15, 2021 |
|
Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer
|
May 21, 2021 |
|
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma
|
Mar 21, 2021 |
|
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
|
Feb 09, 2021 |
|
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade
|
Jan 11, 2021 |
|
Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial
|
Dec 08, 2020 |
|
The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer
|
Nov 10, 2020 |
|
The Landmark Series: Neuroendocrine Tumor Liver Metastases
|
Oct 13, 2020 |
|
Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies
|
Aug 11, 2020 |
|
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases
|
Jul 14, 2020 |
|
Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility
|
Jun 09, 2020 |
|
Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes
|
May 12, 2020 |
|
Germline Genetic Testing: What the Breast Surgeon Needs to Know
|
Apr 07, 2020 |
|
Maintenance of Certification and Continuing Medical Education: Are They Still Required?
|
Mar 10, 2020 |
|
Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer
|
Feb 11, 2020 |
|
Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy
|
Jan 21, 2020 |
|
Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group
|
Dec 10, 2019 |
|
Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy
|
Nov 12, 2019 |
|
Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients
|
Oct 08, 2019 |
|
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
|
Sep 10, 2019 |
|
The 8th Edition of the AJCC Cancer Staging Manual: Breast Cancer
|
Aug 13, 2019 |
|
Melanoma Staging: American Joint Committee on Cancer 8th Edition and Beyond
|
Jul 09, 2019 |
|
The 8th Edition of TNM: Implications for the Surgical Oncologist
|
Jun 11, 2019 |